期刊文献+

Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia 被引量:7

原文传递
导出
摘要 Correction to:Signal Transduction and Targeted Therapy(2022)7:1–13,https://doi.org/10.1038/s41392-021-00870-3 In the original version of this article,given name of 4th author Yannan Jia was incorrectly published as Yanan Jia.The original article has been corrected.Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,which permits use,sharing,adaptation,distribution and reproduction in any medium or format,as long as you give appropriate credit to the original author(s)and the source.
机构地区 不详
出处 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2022年第5期1860-1860,共1页 信号转导与靶向治疗(英文)
  • 相关文献

同被引文献12

引证文献7

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部